Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Platzer Fastigheter in conjunction with the acquisition of AB Volvos real estate portfolio in Gothenburg
Mandate

Vinge advises Platzer Fastigheter in conjunction with the acquisition of AB Volvos real estate portfolio in Gothenburg

February 08, 2017

Vinge has advised Platzer Fastigheter in conjunction with the acquisition of AB Volvo’s real estate portfolio in Gothenburg.

The underlying real estate value amounts to approximately SEK 2.8 billion. The acquired portfolio consists of 338,000 square meters of rentable area as well as land located in Arendal, Torslanda and Säve. The ground area amounts to approximately 3.6 million square meters. The preliminary closing date is 15 December 2016. In order to finance part of the acquisition, Platzer intends to carry out a rights issue of approximately SEK 700 million. In connection with the acquisition, Platzer also intends to utilize bank financing of up to approximately SEK 1.7 billion. Vinge has advised Platzer in all parts of the transaction.

Vinge’s team consisted of partners Olof Jisland, Assur Badur, Charlotte Levin, Louise Brorsson Salomon, counsel Johan Cederblad, partner Robert Deli, associates Christian Lindhé, Anna-Maria Terzi, Anna Lonergan, Ludvig Frithiof, Kristoffer Larsson, Marith Welin-Berger, Emelie Parland and Frida Ställborn.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

 Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

 Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024